HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.

Abstract
We have previously demonstrated that loss of stromal caveolin-1 (Cav-1) in cancer-associated fibroblasts is a strong and independent predictor of poor clinical outcome in human breast cancer patients. However, the signaling mechanism(s) by which Cav-1 downregulation leads to this tumor-promoting microenvironment are not well understood. To address this issue, we performed an unbiased comparative proteomic analysis of wild-type (WT) and Cav-1(-/-) null mammary stromal fibroblasts (MSFs). Our results show that plasminogen activator inhibitor type 1 and type 2 (PAI-1 and PAI-2) expression is significantly increased in Cav-1(-/-) MSFs. To establish a direct cause-effect relationship, we next generated immortalized human fibroblast lines stably overexpressing either PAI-1 or PAI-2. Importantly, PAI-1/2(+) fibroblasts promote the growth of MDA-MB-231 tumors (a human breast cancer cell line) in a murine xenograft model, without any increases in angiogenesis. Similarly, PAI-1/2(+) fibroblasts stimulate experimental metastasis of MDA-MB-231 cells using an in vivo lung colonization assay. Further mechanistic studies revealed that fibroblasts overexpressing PAI-1 or PAI-2 display increased autophagy ("self-eating") and are sufficient to induce mitochondrial biogenesis/activity in adjacent cancer cells, in co-culture experiments. In xenografts, PAI-1/2(+) fibroblasts significantly reduce the apoptosis of MDA-MB-231 tumor cells. The current study provides further support for the "Autophagic Tumor Stroma Model of Cancer" and identifies a novel "extracellular matrix"-based signaling mechanism, by which a loss of stromal Cav-1 generates a metastatic phenotype. Thus, the secretion and remodeling of extracellular matrix components (such as PAI-1/2) can directly regulate both (1) autophagy in stromal fibroblasts and (2) epithelial tumor cell mitochondrial metabolism.
AuthorsRemedios Castello-Cros, Gloria Bonuccelli, Alex Molchansky, Franco Capozza, Agnieszka K Witkiewicz, Ruth C Birbe, Anthony Howell, Richard G Pestell, Diana Whitaker-Menezes, Federica Sotgia, Michael P Lisanti
JournalCell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 10 Issue 12 Pg. 2021-34 (Jun 15 2011) ISSN: 1551-4005 [Electronic] United States
PMID21646868 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Caveolin 1
  • Plasminogen Activator Inhibitor 1
  • Plasminogen Activator Inhibitor 2
Topics
  • Animals
  • Autophagy
  • Breast Neoplasms (pathology)
  • Caveolin 1 (metabolism)
  • Cell Line, Tumor
  • Coculture Techniques
  • Extracellular Matrix (metabolism)
  • Fibroblasts (pathology)
  • Humans
  • Mice
  • Mitochondria (metabolism, pathology)
  • Neoplasm Metastasis
  • Neoplasms (pathology, ultrastructure)
  • Plasminogen Activator Inhibitor 1 (metabolism)
  • Plasminogen Activator Inhibitor 2 (metabolism)
  • Stromal Cells (pathology)
  • Transplantation, Heterologous
  • Tumor Microenvironment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: